CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLORĀ® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE

Go back to CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLORĀ® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE
Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) Delayed: 5.66 -0.06 (1.05%)
Previous Close $5.72    52 Week High $5.95 
Open $5.76    52 Week Low $4.20 
Day High $5.76    P/E 94.33 
Day Low $5.55    EPS $0.06 
Volume 5,998